Endoskeleton TA Interbody Fusion Device Endoskeleton TAS and TAS Hyperlordotic Interbody Fusion Device Endoskeleton TO Interbody Fusion Device Endoskeleton TT Interbody Fusion Device Endoskeleton TC Interbody Fusion Device Endoskeleton TCS Interbody Fusio
Description:
Endoskeleton Interbody Fusion Devices by Titan Spine Inc.
The Endoskeleton Interbody Fusion Device series by Titan Spine Inc. represents a comprehensive range of innovative medical devices designed to address varying patient needs and surgical approaches relating to spinal fusion procedures.
Primary Use: The foremost function of the Endoskeleton devices is to support interbody fusion in spinal surgery, needed due to conditions such as degenerative disc disease, spinal deformities, fractures, or tumors. These devices operate by providing crucial structural support to the vertebrae as native bone tissue grows and fuses the space.
Key Features: The Endoskeleton portfolio includes the TA, TAS, TAS Hyperlordotic, TO, TT, TC, TCS, and TL Interbody Fusion Devices, each with unique specifications to provide personalized care. Functionality includes everything from anti-migration surfaces and numerous footprints to lordotic options and lateral approach devices. This versatility allows surgeons to tailor the spinal fusion surgery per the unique requirements of each patient's anatomy and condition.
Benefits: The comprehensive design and customization options of the Endoskeleton series can potentially contribute to improved patient outcomes. Features aim to promote rapid recovery, reduce postoperative pain, and enhance structural stability, reducing the risk of post-surgery complications.
The Endoskeleton Interbody Fusion Devices provide an exceptional solution for both surgeons and patients, delivering on performance, patient customization, and safety.
Primary Use:
Introduction to the Endoskeleton Interbody Fusion Device Series
The Endoskeleton Interbody Fusion Device Series represents a comprehensive selection of orthopedic implants. This family of devices includes the TA, TAS, TAS Hyperlordotic, TO, TT, TC, TCS, and TL model types.
Primary Medical Use
Cervical and Lumbar Spinal Fusion
The primary function of the Endoskeleton Interbody Fusion Device Series is to aid in spinal fusion surgeries. These surgeries are performed to alleviate conditions such as disc-related back pain, disc herniations, spinal deformity, and instability.
The devices work by creating an "interbody fusion", which involves removing the intervertebral disc and replacing it with the fusion device. Over time, the patient’s natural bone grows through and around the implant, stabilizing the vertebrae above and below the disc space.
Treatment of Degenerative Disc Disease (DDD)
The devices are also commonly used in the treatment of Degenerative Disc Disease (DDD). DDD is characterized by the gradual deterioration of the spinal discs, resulting in pain, weakness, and numbness.
In such cases, the Endoskeleton Interbody Fusion Devices are utilized to eliminate motion at the affected vertebral segment, thereby reducing pain and increasing stability.
Device Variants
Each device variant in the Endoskeleton series has been meticulously crafted to adapt to differing surgical techniques and anatomy. For instance:
TAS Hyperlordotic: Designed for more pronounced cases of spinal curvature, providing additional support and alignment. TT and TO variants: These devices are tailored for transforaminal lumbar interbody fusion and oblique lumbar interbody fusion techniques, respectively.
Conclusion
In conclusion, the Endoskeleton Interbody Fusion Device Series provides a well-equipped arsenal for surgeons, handling complex spine disorders, and enhancing patient recovery processes in the realm of orthopedic implants. Achieving patient comfort, surgical versatility, and superior outcomes stand at the forefront of this innovative device series' use.
How It Works:
Introduction to the Endoskeleton TA Interbody Fusion Device Family
The revolutionary Endoskeleton Interbody Fusion Device family innovates spinal surgery, leading to improved patient outcomes through better stabilization and structural support for the vertebrae. This portfolio includes the Endoskeleton TA, TAS, TAS Hyperlordotic, TO, TT, TC, TCS, and TL Interbody Fusion Devices.
Theory of Operation
All devices within the Endoskeleton family follow a similar operational theory centred around supporting the natural process of spinal fusion. These Orthopedic Implants are designed to be inserted between the vertebral bodies, replacing the intervertebral disc by creating a stable, load-bearing construct that aids in the promotion of bony fusion.
Unique Design Aspects
Each device in this line is made from Titanium alloy, which exhibits superior biocompatibility and strength characteristics. Moreover, the structural design supports three-dimensional bone ingrowth. In simpler terms, the implants encourage the patient's own bone to grow into and throughout the structural design of the implant, leading to a more secure and stable spinal fusion.
Endoskeleton TA, TAS and TAS Hyperlordotic Interbody Fusion Devices features a hollow, cylindrical design with a serrated top surface to minimize implant migration.
Endoskeleton TO, TT, TC, TCS, and TL Interbody Fusion Devices utilize a solid-body design exhibiting a variety of geometrical structures, each suited to different surgical approaches and patient anatomies.
Surgical Utility
The Endoskeleton Interbody Fusion Device family presents considerable utility across a spectrum of spinal fusion procedures. They are commonly used in procedures involving degenerative disc disease, spondylolisthesis, and fracture, resulting from trauma or osteoporosis. The diversified portfolio allows for adoption to a variety of surgical approaches, including anterior, lateral, and posterior procedures.
Implications for Patient Outcomes
With the goal of replacing diseased or damaged intervertebral discs and promoting spinal fusion, the Endoskeleton family capitalizes on device-specific design elements to increase patient outcomes. Enhanced stability, optimized load distribution and the promotion of bone ingrowth contribute to reduced post-operative pain, decreased recovery times and improved long-term patient health.
To conclude, the Endoskeleton TA Interbody Fusion Device family presents a significant advancement in the realm of Orthopedic Implants, blending innovative design with high functionality to enhance surgical results and patient recoveries.
Manufacturer:
Titan Spine Inc
Status: In Stock
Are you the owner or manufacturer of this device? Need to update anything on this page or get in touch with us? Click here.